Globeflex Capital’s Altimmune ALT Stock Holding History

Globeflex Capital’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1	Closed	-$1K	–	505
2015 Q1	$1K	Sell	1 -1	-50%	-$498	﹤0.01%	413
2014 Q4	$1K	Hold	2	–	–	﹤0.01%	415
2014 Q3	$1K	Sell	2 -1	-33%	-$523	﹤0.01%	434
2014 Q2	$1K	Buy	3 +1	+50%	+$452	﹤0.01%	482
2014 Q1	$1K	Hold	2	–	–	﹤0.01%	489
2013 Q4	$1K	Hold	2	–	–	﹤0.01%	495
2013 Q3	$1K	Buy	+2	New	+$1.15K	﹤0.01%	472

Other funds holding ALT

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

GMCM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

Globeflex Capital's ALT Position: Q2 2015 in Review

Globeflex Capital sold out of Altimmune (ALT) in Q2 2015, closing a stake of 1 share — an estimated $1K sold.

Globeflex Capital first reported a position in ALT in Q3 2013 and held it in 7 quarters. The position peaked at $1K in Q1 2015. 34 funds tracked by Wall St. Rank hold ALT as of Q2 2015.

Globeflex Capital reported no remaining Altimmune position as of Q2 2015 after selling out during the quarter.
Globeflex Capital sold 1 Altimmune share in Q2 2015, an estimated $1K.
Globeflex Capital first reported a position in Altimmune in Q3 2013 and held it in 7 quarters.
Globeflex Capital's Altimmune position peaked at $1K in Q1 2015.
34 funds tracked by Wall St. Rank held Altimmune as of Q2 2015.

Based on Globeflex Capital's 13F filing for Q2 2015, filed 5 Aug 2015.